Levoleucovorin Calcium

Phase 2Small molecule

SSouthwest Autism Research & Resource Center

Levoleucovorin Calcium is one of 68 small molecule programs targeting Autism Spectrum Disorder. It is currently in Phase 2.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Autism Spectrum DisorderRecruiting

AutismRecruiting

Autism Spectrum DisorderPhase 2

Recruiting

AutismPhase 2

Recruiting

Competition

Competitive Landscape

56 competitors in Autism Spectrum Disorder

#DrugCompanyPhaseTrials

Buspar

Bristol-Myers Squibb

Approved

4 2

Namenda

AbbVie

Approved

3 3

Marinol

Lioresal

Epidiolex

Aricept

Abilify

2 8

Neurontin

VViatris Specialty LLC

Approved

2 9

Strattera

MMap77

Approved

1 10

Bendopa

MMerz North America, Inc.

Approved

—

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Autism Spectrum Disorder1 trial

Early Treatment of Language Impairment in Young Children With Autism Spectrum Disorder With Leucovorin Calcium

Recruiting·SSouthwest Autism Research & Resource Center·Phase 2·NCT04060017·80 enrolled

Autism1 trial

Treatment of Social and Language Deficits With Leucovorin for Young Children With Autism

Recruiting·SSouthwest Autism Research & Resource Center·Phase 2·NCT04060030·80 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for Levoleucovorin Calcium. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Levoleucovorin Calcium compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Levoleucovorin Calcium. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Southwest Autism Research & Resource Center company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 2[1]
Company: SSouthwest Autism Research & Resource Center

Levoleucovorin Calcium

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Autism Spectrum Disorder1 trial

Autism1 trial

References

Drug Info

Quick Facts

Related News